MDCO - Stock Quote for Medicines Co - MSN Money

Dow +150.25

+1.52%
10,058.64

Nasdaq +24.82

+1.17%
2,150.87

S&P +13.78

+1.30%
1,070.52

U.S. markets closed

|CustomizeMDCO quote (NASDAQ Exchange)

7.66 +0.25 +3.37%
After Hours: 7.41 -0.25/-3.26% Vol. 5,432
Previous Close	7.41	Bid	6.85
Open	7.53	Bid Size	100
Day's High	7.67	Ask	9.35
Day's Low	7.38	Ask Size	200
Volume	489,127	52 Week High	14.51
Avg. Daily Vol. (13 wk.)	337,480	52 Week Low	6.15

MDCO Intraday Chart

5d 1m 3m 1y 3y 5y 10y

Beta	0.76
Dividend & Yield	NA
Earnings/Share	-0.13
Forward P/E	26.41
Market Cap.	404.99 Mil
P/E	10.21
Return on Equity	-2.29
Total Shares Out.	52.87 Mil

Quotes delayed 15 min unless otherwise indicated

Last trade (extended hours) 02/09/2010 5:00 PM ET Financial data in U.S. dollars

Your latest quotes: ADUEF, SXT, C, MDCO, PHII, ARA

News about MDCO

Market Report -- In Play (MDCO) 1/4/2010 Briefing.com
Market Report -- In Play (MDCO) 12/22/2009 Briefing.com
Medicines Co. suing Teva, Pliva again over patent 1/4/2010 Associated Press
Medicines Co. buys Pfizer heart drug candidate 12/22/2009 Associated Press
View all MDCO news

Press releases

Zacks Industry Outlook Highlights: GlaxoSmithKline, Eli Lilly & Co., The Medicines Company and Genzyme Corporation 1/29/2010 Business Wire
The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635 1/15/2010 Market Wire
View all MDCO news

News from the Web

In Depth: 10 Questions About High Cholesterol 2/3/2010 At Forbes
UPDATE 1-Medicines Co cuts 10 pct jobs, sees charges 1/12/2010 At Thomson Reuters
Pfizer's Having a Garage Sale 1/8/2010 At Motley Fool
$ Medicines Co.'s Lackluster Pfizer Deal 12/24/2009 At Barron's
View all MDCO news

Videos about MDCO

A time for everything

A time for everything

A few notes from investor presentations, Cynthia's tidbits, Cynthia's parabolic stories, Cynthia's parables, Cynthia's...

From Our Sponsors

Stock ratings

	Community Stock Ratings
	CAPS Rating:

111 users rated this stock

3	Rating: 3 out of 10 Read full report How StockScouter works

Analyst recommendation

Recommendation: Hold

View analyst ratings

More information for MDCO

Financial highlights

Sales*	396.05 Mil
Income*	-6.93 Mil
Sales Growth*	+35.20%
Income Growth*	+75.80%
Net Profit Margin	-1.75%
Debt/Equity Ratio	NA

* last 12 months

More financial information

Funds that own MDCO

Fund Name	% Own
Pictet Funds (Lux) Biotech	7.0
T. Rowe Price Health Sciences Fund	5.1
Eaton Vance Worldwide Health Sciences Fund	2.2
View all funds

advertisement

Market update 9:01pm ET

7 things to ask before buying a stock

Putting your money in the market can leave you open to some nasty surprises. Avoid them by doing the right research.

More market news

Market Talk With Jim Jubak message board

Go to the Market Talk With Jim Jubak message board

advertisement

Data providers
Copyright © 2010 Thomson Reuters. Click for Restrictions.
Free Real-Time quotes provided by BATS Exchange, Inc.
Analyst Recommendations data provided by Zacks.com.
Quotes supplied by Interactive Data Real-Time Services.
StockScouter data provided by Gradient Analytics, Inc.

Page generated 12:01 AM Eastern Time

© Microsoft